Table II.
Cell proliferation inhibition, % | |||||
---|---|---|---|---|---|
Mutation | Oxaliplatin | Irinotecan | SN-38 | 5-FU | P-value |
E17K | 66.22±0.67 | 28.56±1.31 | 30.38±1.09 | 21.59±0.06 | 0.019 |
E49K | 78.25±3.30 | 29.95±0.26 | 48.68±1.29 | 24.39±0.55 | 0.016 |
L52R | 64.48±0.28 | 31.52±0.23 | 33.81±1.22 | 21.52±0.58 | 0.016 |
T41A | 79.88±0.68 | 33.83±1.30 | 41.07±1.71 | 25.36±0.24 | 0.016 |
S45F | 90.59±2.42 | 32.92±1.10 | 45.18±0.89 | 33.36±0.54 | 0.024 |
S33P | 82.25±1.86 | 34.55±1.20 | 44.23±1.39 | 28.89±1.50 | 0.016 |
Data are expressed as mean ± standard deviation (n=3). Data are cell proliferation inhibition (%) values obtained when drugs are administered at a dose of 10 µg/ml for 72 h. 5-FU, 5-fluorouracil.